Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Trans fat labeling

This article was originally published in The Tan Sheet

Executive Summary

"The estimate of the amount of time needed, not exceeding 12 months, to exhaust the number of existing labels for all products identified that the firm is requesting to use," is one factor CFSAN will take into account when reviewing requests for extensions on compliance with the trans fat labeling final rule, according to a 1guidance released by the Center for Food Safety & Applied Nutrition. According to the center, the guidance will publish in an upcoming issue of the Federal Register. FDA "does not object" to the use of "alternate means of compliance" such as a sticker label declaring the amount of trans fat in a product as long as the sticker "adheres to the package under intended storage conditions," the guidance states. The final rule on trans fat labeling was released in 2003 (2"The Tan Sheet" July 14, 2003, p. 7)...

You may also be interested in...



Trans fat labeling

FDA has added an addendum to its recent guidance on requesting an extension to use existing label stock after the trans fat labeling effective date of Jan. 1, the agency said Dec. 30. Due to the "numerous requests" from industry on the guidance and the agency's "limited resources to handle all of these pending requests prior to the Jan. 1 effective date," FDA will only consider requests postmarked as of Dec. 31. In order to be considered, the requests must be for product labels that otherwise comply with FDA labeling requirements. The product also must not contain more than 0.5 g trans fat per labeled serving. The labeling guidance was released Dec. 14 (1"The Tan Sheet" Dec. 12, 2005, In Brief)...

Supplement Trans Fat Label Additions Stipulated Under FDA Final Rule

Manufacturers of dietary supplements that contain more than .5 g of trans fat will be required to list the amount of the ingredient, as well as the amounts of saturated fat and cholesterol, on the Supplement Facts panel by Jan. 1, 2006

Teva Debuts US Azopt Rival

Teva has launched the first and so far only US generic version of Novartis’ Azopt treatment for ocular hypertension, with the brinzolamide 1% solution having been developed and manufactured by Indoco Remedies.

Topics

UsernamePublicRestriction

Register

OM016276

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel